The Vanguard Group 13D and 13G filings for AngioDynamics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Sale | 2023-12-29 | 13G | AngioDynamics, Inc. ANGO | The Vanguard Group | 2,268,461 5.690% | -513,332 (-18.45%) | Filing |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | AngioDynamics, Inc. ANGO | The Vanguard Group | 2,781,793 7.110% | 220,569 (+8.61%) | Filing |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | AngioDynamics, Inc. ANGO | The Vanguard Group | 2,561,224 6.630% | 330,101 (+14.80%) | Filing |
| 2021-02-10 10:30 am Sale | 2020-12-31 | 13G | AngioDynamics, Inc. ANGO | The Vanguard Group | 2,231,123 5.880% | -139,576 (-5.89%) | Filing |